Gut microbiota promotes obesity-associated liver cancer through pge2-mediated suppression of antitumor immunity.
Published version of a preprint
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Obesity increases the risk of cancers, including hepatocellular carcinomas (HCC). However, the precise molecular mechanisms through which obesity promotes HCC development are still unclear. Recent studies have shown that gut microbiota may influence liver diseases by transferring its metabolites and components. Here, we show that the hepatic translocation of obesity-induced lipoteichoic acid (LTA), a Gram-positive gut microbial component, promotes HCC development by creating a tumor-promoting microenvironment. LTA enhances the senescence-associated secretory phenotype (SASP) of hepatic stellate cells (HSC) collaboratively with an obesity-induced gut microbial metabolite, deoxycholic acid, to upregulate the expression of SASP factors and COX2 through Toll-like receptor 2. Interestingly, COX2-mediated prostaglandin E2 (PGE2) production suppresses the antitumor immunity through a PTGER4 receptor, thereby contributing to HCC progression. Moreover, COX2 overexpression and excess PGE2 production were detected in HSCs in human HCCs with noncirrhotic, nonalcoholic steatohepatitis (NASH), indicating that a similar mechanism could function in humans. Significance: We showed the importance of the gut–liver axis in obesity-associated HCC. The gut microbiota–driven COX2 pathway produced the lipid mediator PGE2 in senescent HSCs in the tumor microenvironment, which plays a pivotal role in suppressing antitumor immunity, suggesting that PGE2 and its receptor may be novel therapeutic targets for noncirrhotic NASH-associated HCC. Cancer Discov; 7(5); 522–38. ©2017 AACR. This article is highlighted in the In This Issue feature, p. 443
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, it has become apparent that toll‐like receptors (TLR), an innate immune receptor, can trigger SASP induction.48, 59, 60”
From Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer (2020) · cites this paper as [48]
In the citing paper
“COX‐2 induces overproduction of prostaglandin E2 (PGE2), resulting in suppression of anti–tumor immunity and progression of obesity‐associated HCC.48”
From Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer (2020) · cites this paper as [48]
In the citing paper
“TLR2 stimulation induces expression of SASP factors through the NF‐κB signaling pathway to promote development of obesity‐associated HCC.48”
From Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer (2020) · cites this paper as [48]
In the citing paper
“Recently TLR, an innate immune receptor which recognizes pathogen-associated molecular patterns (PAMPs) and damage associated molecular patterns (DAMPs), was shown to trigger induction of SASP (Davalos et al., 2013; Kawasaki and Kawai, 2014; Loo et al., 2017, 2020; Hari et al., 2019).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Loo et al., 2017
In the citing paper
“Lipoteichoic acid (LTA), a component of the cell wall of gram positive gut microbiota is recognized by TLR2 and induces expression of SASP components creating a tumor promoting micro environment that promotes development of obesity associated hepatocellular carcinoma (Loo et al., 2017).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Loo et al., 2017
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 1×
“4), consistent with previous reports (27).”
Forner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613 · cited 2×
“Obesity has become a worldwide health problem and is known to increase the risk of diabetes, cardiovascular disease, and several types of cancer (1).”
BackgroundT cell exclusion, immune privilege, and the tumor microenvironment
Joyce, J. A., & Fearon, D. T. (2015) · Science · doi:10.1126/science.aaa6204 · Cited by 2,473 · cited 1×
“The PD-1 blockade can recover the functions of effector T cells, and an anti–PD-1 antibody is now being clinically used for the treatment of various cancers (48, 49).”
BackgroundA complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 1×
“Indeed, the paracrine effects of SASP have been reported to be dependent on the surrounding cells (17), particularly on the p53 status of these cells (18).”
BackgroundObesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219 · cited 10×
“This recently identified phenotype of senescent cells involves secretion of a series of inflammatory cytokines, chemokines, matrix-remodeling factors, and growth factors (7), suggesting that the gut–liver axis plays a pivotal role in inducing cellular senescence of HSCs and liver tumorigenesis (4).”
BackgroundSelf-citationFour faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070 · cited 1×
“This recently identified phenotype of senescent cells involves secretion of a series of inflammatory cytokines, chemokines, matrix-remodeling factors, and growth factors (7), suggesting that the gut–liver axis plays a pivotal role in inducing cellular senescence of HSCs and liver tumorigenesis (4).”
BackgroundAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Self-citationSenescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Wang, D., & DuBois, R. N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2809 · Cited by 1,793
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
Kang, T.-W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., et al. (2011) · Nature · doi:10.1038/nature10599 · Cited by 1,621
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428 · cited 1×
“The importance of the SASP phenotype has also been recognized in vivo in a variety of pathophysiologic contexts, giving rise to not only deleterious effects such as chronic inflammation and tumorigenesis (4, 8, 9), but also beneficial effects such as embryonal development (10, 11), immunosurveillance (12–14), and tiss…”
BackgroundPromotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dapito, D. H., Mencin, A., Gwak, G.-Y., Pradere, J.-P., Jang, M.-K., Mederacke, I., Caviglia, J. M., Khiabanian, H., Adeyemi, A., Bataller, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.007 · Cited by 1,346 · cited 2×
“In addition, previous in vivo studies have demonstrated that TLR4-mediated inflammatory signals induced by the Gram-negative bacterial component lipopolysaccharide (LPS) are important for promoting liver fibrosis and fibrosis-associated liver tumorigenesis (26).”
BackgroundFuertes, M. B., Kacha, A. K., Kline, J., Woo, S.-R., Kranz, D. M., Murphy, K. M., & Gajewski, T. F. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101159 · Cited by 1,192
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186
Resolvin E1 and protectin D1 activate inflammation-resolution programmes
Schwab, J. M., Chiang, N., Arita, M., & Serhan, C. N. (2007) · Nature · doi:10.1038/nature05877 · Cited by 1,184
Self-citationProstaglandins as modulators of immunity
Harris, S. G., Padilla, J., Koumas, L., Ray, D., & Phipps, R. P. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02154-8 · Cited by 1,180 · cited 1×
“On the other hand, because PGs have been reported to affect immune cells (36), we examined the effects of PGs on immune cells in the tumor microenvironment.”
BackgroundCyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
Zelenay, S., van der Veen, A. G., Böttcher, J. P., Snelgrove, K. J., Rogers, N., Acton, S. E., Chakravarty, P., Girotti, M. R., Marais, R., Quezada, S. A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.015 · Cited by 1,128 · cited 1×
“Although the frequencies of CD11chi MHC class IIhi dendritic cells (DC) and CD11b+ DCs were not changed, the population of CD103+ DCs, which are essential for anticancer immune responses (39, 40), was increased in the AAT-008–treated group (Fig.”
BackgroundSenescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124 · cited 1×
“The importance of the SASP phenotype has also been recognized in vivo in a variety of pathophysiologic contexts, giving rise to not only deleterious effects such as chronic inflammation and tumorigenesis (4, 8, 9), but also beneficial effects such as embryonal development (10, 11), immunosurveillance (12–14), and tiss…”
BackgroundJun, J.-I., & Lau, L. F. (2010) · Nature Cell Biology · doi:10.1038/ncb2070 · Cited by 998 · cited 1×
“The importance of the SASP phenotype has also been recognized in vivo in a variety of pathophysiologic contexts, giving rise to not only deleterious effects such as chronic inflammation and tumorigenesis (4, 8, 9), but also beneficial effects such as embryonal development (10, 11), immunosurveillance (12–14), and tiss…”
BackgroundThe DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4.
Kang, C., Xu, Q., Martin, T. D., Li, M. Z., Demaria, M., Aron, L., Lu, T., Yankner, B. A., Campisi, J., & Elledge, S. J. (2015) · Science · doi:10.1126/science.aaa5612 · Cited by 982
Michelotti, G. A., Machado, M. V., & Diehl, A. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.183 · Cited by 974 · cited 2×
“However, obesity-associated nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) have recently emerged as important risk factors for liver cancer (6).”
BackgroundProstaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axis
Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005) · Science · doi:10.1126/science.1116221 · Cited by 883
Obesity, Inflammation, and Cancer
Deng, T., Lyon, C. J., Bergin, S., Caligiuri, M. A., & Hsueh, W. A. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044359 · Cited by 794
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence
Kaplon, J., Zheng, L., Meissl, K., Chaneton, B., Selivanov, V. A., Mackay, G., van der Burg, S. H., Verdegaal, E. M. E., Cascante, M., Shlomi, T., et al. (2013) · Nature · doi:10.1038/nature12154 · Cited by 633
Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance
Kurtova, A. V., Xiao, J., Mo, Q., Pazhanisamy, S., Krasnow, R., Lerner, S. P., Chen, F., Roh, T. T., Lay, E., Ho, P. L., et al. (2015) · Nature · doi:10.1038/nature14034 · Cited by 578 · cited 1×
“PGE2 staining was performed as previously reported (50).”
MethodThe Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza
Morita, M., Kuba, K., Ichikawa, A., Nakayama, M., Katahira, J., Iwamoto, R., Watanebe, T., Sakabe, S., Daidoji, T., Nakamura, S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.02.027 · Cited by 459 · cited 1×
“Therefore, to analyze whether PUFAs were overproduced in HFD-induced liver tumors, liver tissues from DMBA-treated, HFD-fed mice were subjected to LC/ MS-MS–based lipidomics analysis (31).”
MethodSelf-citationp53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes
Davalos, A. R., Kawahara, M., Malhotra, G. K., Schaum, N., Huang, J., Ved, U., Beausejour, C. M., Coppe, J.-P., Rodier, F., & Campisi, J. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201206006 · Cited by 439 · cited 1×
“High mobility group box 1 (HMGB1) activates TLR4-mediated cytokine signals in an autocrine manner in senescent cells (25).”
BackgroundSawey, E. T., Chanrion, M., Cai, C., Wu, G., Zhang, J., Zender, L., Zhao, A., Busuttil, R. W., Yee, H., Stein, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.040 · Cited by 436 · cited 1×
“Although these reports have focused on the initial onset of liver carcinogenesis (44), the progression mechanisms of obesityassociated liver cancer are still incompletely understood, particularly in the context of the gut–liver axis.”
BackgroundCellular senescence: a link between cancer and age-related degenerative disease?
Campisi, J., Andersen, J. K., Kapahi, P., & Melov, S. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.001 · Cited by 421 · cited 1×
“The importance of the SASP phenotype has also been recognized in vivo in a variety of pathophysiologic contexts, giving rise to not only deleterious effects such as chronic inflammation and tumorigenesis (4, 8, 9), but also beneficial effects such as embryonal development (10, 11), immunosurveillance (12–14), and tiss…”
BackgroundBRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance
Tasdemir, N., Banito, A., Roe, J.-S., Alonso-Curbelo, D., Camiolo, M., Tschaharganeh, D. F., Huang, C.-H., Aksoy, O., Bolden, J. E., Chen, C.-C., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0217 · Cited by 415
Wang, L., Fouts, D. E., Stärkel, P., Hartmann, P., Chen, P., Llorente, C., DePew, J., Moncera, K., Ho, S. B., Brenner, D. A., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.003 · Cited by 389 · cited 1×
“Recent studies have provided insight into the effects of the gut–liver axis in some liver diseases, such as fatty liver, hepatitis, liver fibrosis, and HCC with fibrosis (4, 28, 45); these effects are thought to be mediated by absorption of intestinal contents, including gut microbiota–related metabolites and componen…”
BackgroundObesity and Cancer: The Oil that Feeds the Flame
Font-Burgada, J., Sun, B., & Karin, M. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.015 · Cited by 356 · cited 1×
“Previous reports have suggested that endoplasmic reticulum stress, p62/SQSTM accumulation, and increased mitochondrial ROS levels in hepatocytes are important causes of hepatocyte carcinogenesis (3).”
BackgroundRole of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease
Miura, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7381 · Cited by 355
Oshima, H., Matsunaga, A., Fujimura, T., Tsukamoto, T., Taketo, M. M., & Oshima, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.014 · Cited by 240
Self-citationA Senescence-Inflammatory Switch from Cancer-Inhibitory to Cancer-Promoting Mechanism
Pribluda, A., Elyada, E., Wiener, Z., Hamza, H., Goldstein, R. E., Biton, M., Burstain, I., Morgenstern, Y., Brachya, G., Billauer, H., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.06.005 · Cited by 239 · cited 1×
“Indeed, the paracrine effects of SASP have been reported to be dependent on the surrounding cells (17), particularly on the p53 status of these cells (18).”
BackgroundDynamic Treg interactions with intratumoral APCs promote local CTL dysfunction
Bauer, C. A., Kim, E. Y., Marangoni, F., Carrizosa, E., Claudio, N. M., & Mempel, T. R. (2014) · Journal of Clinical Investigation · doi:10.1172/jci66375 · Cited by 238 · cited 1×
“Tregs can potently inhibit antitumor T-cell responses and can induce the expression of inhibitory molecules, such as PD-1, on CD8+ T cells (47).”
Backgroundp53, ROS and senescence in the control of aging
Vigneron, A., & Vousden, K. H. (2010) · Aging · doi:10.18632/aging.100189 · Cited by 221 · cited 1×
“However, the trigger that initiates the SASP signals may vary depending on physiologic status, and thus the precise mechanisms regulating the expression of SASP factors need to be elucidated in each pathophysiologic setting (24).”
BackgroundTakahashi, A., Imai, Y., Yamakoshi, K., Kuninaka, S., Ohtani, N., Yoshimoto, S., Hori, S., Tachibana, M., Anderton, E., Takeuchi, T., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.10.018 · Cited by 205 · cited 1×
“Quantitative PCR Total RNA was extracted from mouse tissues or cultured cells using TRIzol reagent (Life Technologies) and reverse transcription and quantitative PCR were performed as previously described (23).”
MethodSelf-citationGut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
Fukui, H. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.425 · Cited by 196 · cited 2×
“The gut microbial overgrowth and increased hepatic translocation of the gut microbial components and metabolites from the intestine, the so-called gut–liver axis, are known to play a role in the pathogenesis of liver disorders (26, 28).”
BackgroundChen, J. H., Perry, C. J., Tsui, Y.-C., Staron, M. M., Parish, I. A., Dominguez, C. X., Rosenberg, D. W., & Kaech, S. M. (2015) · Nature Medicine · doi:10.1038/nm.3831 · Cited by 172 · cited 5×
“PGE2 is known to function through four receptors, i.e., PTGER1, PTGER2, PTGER3, and PTGER4, a family of G protein–coupled receptors (37, 38).”
BackgroundInfluentialRai, T. S., Cole, J. J., Nelson, D. M., Dikovskaya, D., Faller, W. J., Vizioli, M. G., Hewitt, R. N., Anannya, O., McBryan, T., Manoharan, I., et al. (2014) · Genes & Development · doi:10.1101/gad.247528.114 · Cited by 162
Mediator lipidomics in acute inflammation and resolution
Arita, M. (2012) · The Journal of Biochemistry · doi:10.1093/jb/mvs092 · Cited by 145 · cited 1×
“Mediator Lipidomics LC/MS-MS–based lipidomics analyses were performed using a high-performance liquid chromatography system (Waters UPLC) with a linear ion-trap quadrupole mass spectrometer (QTRAP5500; AB SCIEX) equipped with an Acquity UPLC BEH C18 column (Waters) as described previously (30).”
MethodSelf-citationTakuma, Y., & Nouso, K. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i12.1436 · Cited by 135 · cited 3×
“Owing to the increased incidence of obesityassociated HCC (42), the mechanisms involved in this disease have been extensively investigated.”
BackgroundSoontrapa, K., Honda, T., Sakata, D., Yao, C., Hirata, T., Hori, S., Matsuoka, T., Kita, Y., Shimizu, T., Kabashima, K., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018625108 · Cited by 121 · cited 5×
“PGE2 is known to function through four receptors, i.e., PTGER1, PTGER2, PTGER3, and PTGER4, a family of G protein–coupled receptors (37, 38).”
BackgroundSelf-citationPerumpail, R. B., Wong, R. J., Ahmed, A., & Harrison, S. A. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3821-7 · Cited by 111 · cited 2×
“Approximately 20% of NASH-associated HCC is nonfibrotic and arises directly from NAFLD-based NASH (41, 42), and this is categorized as noncirrhotic NASHassociated HCC.”
BackgroundUnexpected Pieces to the Senescence Puzzle
Cichowski, K. M., & Hahn, W. C. (2008) · Cell · doi:10.1016/j.cell.2008.05.027 · Cited by 86
The Impact of Obesity on Liver Histology
Goodman, Z. D. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.010 · Cited by 49 · cited 2×
“Moreover, PGs are known to affect immune cells (29).”
BackgroundDiscovery of AAT-008, a novel, potent, and selective prostaglandin EP4 receptor antagonist
Okumura, Y., Yamagishi, T., Nukui, S., & Nakao, K. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.01.067 · Cited by 20 · cited 2×
“97 nmol/L for human PTGER4), and its activity against human, mouse, and rat PTGER4 receptors was examined and proven equivalent (49).”
Background
Research works printed but not linked: 1
- Forman, 2014, The global and regional burden of cancer, 16
Cited by
Interaction between microbiota and immunity in health and disease
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Research · doi:10.1038/s41422-020-0332-7 · Cited by 3,947
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
“Recently TLR, an innate immune receptor which recognizes pathogen-associated molecular patterns (PAMPs) and damage associated molecular patterns (DAMPs), was shown to trigger induction of SASP (Davalos et al., 2013; Kawasaki and Kawai, 2014; Loo et al., 2017, 2020; Hari et al., 2019).”
BackgroundUnmasking senescence: context-dependent effects of SASP in cancer
Faget, D. V., Ren, Q., & Stewart, S. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0156-2 · Cited by 863
Zhang, X., Coker, O. O., Chu, E. S., Fu, K., Lau, H. C. H., Wang, Y.-X., Chan, A. W. H., Wei, H., Yang, X., Sung, J. J. Y., et al. (2021) · Gut · doi:10.1136/gutjnl-2019-319664 · Cited by 841
Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence
Kerr, J., Anderson, C., & Lippman, S. M. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30411-4 · Cited by 677
Metadata
- Authors
- Loo, T. M., Kamachi, F., Watanabe, Y., Yoshimoto, S., Kanda, H., Arai, Y., Nakajima-Takagi, Y., Iwama, A., Koga, T., Sugimoto, Y., Ozawa, T., Nakamura, M., Kumagai, M., Watashi, K., Taketo, M. M., Aoki, T., Narumiya, S., Oshima, M., Arita, M., Hara, E., & Ohtani, N.
- Affiliations
- Tokyo University of Science (JP)
- Japanese Foundation For Cancer Research (JP)
- 5Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
- Chiba University (JP)
- Kumamoto University (JP)
- National Institute of Infectious Diseases (JP)
- Kyoto University (JP)
- Kanazawa University (JP)
- Keio University (JP)
- Japan Agency for Medical Research and Development (JP)
- ORCID
- Venue
- Cancer Discovery
- Published
- 2017-04-30
- Volume
- 7
- Issue
- 5
- Pages
- 522-538
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W2588201913
- Semantic Scholar
- d170c622d8ac72567e131da3c3405f2b4094f88b
- Cited by
- 478
- References
- 49
- Citations by year
- 2026: 35 · 2025: 51 · 2024: 58 · 2023: 66 · 2022: 74 · 2021: 72 · 2020: 50 · 2019: 33 · 2018: 27 · 2017: 12
- FWCI
- 13.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (26670030, 15H04648, 14J06998, 17H01531, 26250028, 15K12709, 15H05898, 16H04699, 15K19031, 17H03990, 15H05905, 16H06276, 26460565, 15H05897)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- gut microbiota, obesity, hepatocellular carcinoma, lipoteichoic acid, deoxycholic acid, hepatic stellate cells, senescence-associated secretory phenotype, cyclooxygenase-2, prostaglandin E2, EP4 receptor, TLR2, antitumor immunity, gut-liver axis, nonalcoholic steatohepatitis, tumor microenvironment
- MeSH terms
- Gastrointestinal Microbiome, Animals, Female, Carcinoma, Hepatocellular, Humans, Lipopolysaccharides, Liver Neoplasms, Male, Mice, Inbred C57BL, Obesity, Teichoic Acids, Dinoprostone, Tumor Escape, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.